⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 22, 2026

Adempas 2,5 mg Filmtabletten 2,5 mg (Filmtablette)

📷 Wikipedia: Riociguat · Source
Adempas 2,5 mg Filmtabletten 2,5 mg (Filmtablette)
📷 Wikipedia: Riociguat · Source
Adempas 2.5 mg film-coated tablets are subject to a parallel export ban.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 35 days ago.
📈 Timeline
5 days in total
May 18, 2026 May 23, 2026

What is this? Adempas is a medicine with the active ingredient riociguat. It comes as small tablets in a blister pack.

What's happening? Some packs of Adempas 2.5 mg are not available right now. The 42-tablet box is out of stock until May 2026.

Does this affect me? If you take Adempas 2.5 mg, check if you have the 42-tablet pack. The 84-tablet pack is still available.

What should I do? Talk to your pharmacist or doctor before changing how you take your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
RIOCIGUAT
Agency-published detail

🚫 Parallel export ban active · ATC: C02KX · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Bayer AG, Kaiser-Wilhelm-Allee 1, 51368 Leverkusen, Federal Republic of Germany · Affected packs: 42 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-21, resupply 2026-05-20] · 84 Stück Schachtel, Blisterpackung [verfügbar]

First published
April 22, 2026
Last refreshed by us
4 days ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 3 weeks ago

Adempas 0,5 mg Filmtabletten 0,5 mg (Filmtablette)

Adempas 0.5 mg film-coated tablets are subject to a parallel export ban.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Adempas 2,5 mg Filmtabletten 2,5 mg (Filmtablette). Adempas 2.5 mg film-coated tablets are subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on April 22, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.